false 0001716621 0001716621 2025-01-29 2025-01-29
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):
 
January 29, 2025
 
 
 
Catheter Precision, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
 
Delaware
001-38677
38-3661826
(State or other jurisdiction of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
 
1670 Highway 160 West
Suite 205
Fort Mill, SC 29708
(Address of principal executive offices, including zip code)
 
 
(973) 691-2000
(Registrant’s telephone number, including area code)
 
N/A
(Former name or former address, if changed since last report.)
-----------------------------
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.0001 per share
VTAK
NYSE American
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2):
 
Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 
 
 
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
Grants of Incentive Stock Options to Executive Officers.
 
On January 29, 2025, the Compensation Committee of the Board of Directors of Catheter Precision, Inc. (the “Company”) awarded incentive stock option grants to the following executive officers of the Company pursuant to the Company’s 2023 Executive Incentive Plan:
 
David Jenkins, Chairman of the Board and Chief Executive Officer
 
Mr. Jenkins received options to purchase 450,000 shares of Company common stock at an exercise price of $0.42. The options have a term of ten years and vest according to the following schedule:
 
 
●
90,000 shares vested on January 29, 2025
 
●
120,000 shares vest on January 29, 2026
 
●
120,000 shares vest on January 29, 2027, and
 
●
120,000 shares vest on January 29, 2028.
 
 
Marie-Claude Jacques, Chief Commercial Officer
 
Ms. Claude received options to purchase 250,000 shares of Company common stock at an exercise price of $0.42. The options have a term of ten years and vest according to the following schedule:
 
125,000 options vest as follows:
 
 
●
20% vested on January 29, 2025
 
●
20% vest on January 29, 2026
 
●
20% vest on January 29, 2027
 
●
20% vest on January 29, 2028, and
 
●
20% vest on January 29, 2029.
 
An additional 125,000 options vest as follows:
 
 
●
25% vest on March 31, 2025 if Q1 2025 sales targets are achieved
 
●
25% vest on June 30, 2025 if Q2 2025 sales targets are achieved
 
●
25% vest on September 30, 2025 if Q3 2025 sales targets are achieved, and
 
●
25% vest on December 31, 2025 if Q4 2025 sales targets are achieved.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
CATHETER PRECISION, INC.
 
 
Date: February 4, 2025                                                                   
By: /s/ Philip Anderson                           
Philip Anderson
Chief Financial Officer
 
 
v3.25.0.1
Document And Entity Information
Jan. 29, 2025
Document Information [Line Items]  
Entity, Registrant Name Catheter Precision, Inc.
Document, Type 8-K
Document, Period End Date Jan. 29, 2025
Entity, Incorporation, State or Country Code DE
Entity, File Number 001-38677
Entity, Tax Identification Number 38-3661826
Entity, Address, Address Line One 1670 Highway 160 West
Entity, Address, Address Line Two Suite 205
Entity, Address, City or Town Fort Mill
Entity, Address, State or Province SC
Entity, Address, Postal Zip Code 29708
City Area Code 973
Local Phone Number 691-2000
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol VTAK
Security Exchange Name NYSE
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001716621
Catheter Precision (AMEX:VTAK)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Catheter Precision
Catheter Precision (AMEX:VTAK)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Catheter Precision